To delineate the influence of FAK on HCC progression, we generated FAK-deficient C57BL/6 mice (C57BL/6-FAK−/−) and compared tumor growth with their wild-type counterparts (C57BL/6-FAK+/+). Here, PTK2 is linked to hepatocellular carcinoma.